Early research (Phase 1)Study completedNCT02337283
What this trial is testing
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)
Who this might be right for
Healthy
Boehringer Ingelheim 96